Personalized neuroscience is an emerging interdisciplinary field that intersects neuroscience and personalized medicine, aiming to decipher individual variations in brain structure, function, and connectivity to customize interventions and treatments for diverse neurological and psychiatric conditions. Unlike conventional neuroscience approaches that often generalize findings across populations, personalized neuroscience recognizes the inherent diversity in brain function and treatment responses among individuals. Leveraging cutting-edge technologies such as functional magnetic resonance imaging (fMRI), electroencephalography (EEG), and genetics, researchers can delve deeper into the unique characteristics of each person's brain. A pivotal aspect of personalized neuroscience involves the use of biomarkers—genetic markers, neural activity patterns, and neuroimaging signatures—to characterize brain health and forecast responses to interventions. By pinpointing these biomarkers, clinicians can devise personalized treatment strategies tailored to an individual's distinct neurobiological profile. This approach holds promise across various domains, including mental health, neurodegenerative diseases, and cognitive enhancement. In psychiatry, personalized neuroscience enables optimization of medication selection and dosages based on a patient's neurobiological makeup, potentially minimizing side effects and enhancing treatment outcomes. Likewise, in neurodegenerative disorders like Alzheimer's and Parkinson's, it facilitates early detection and intervention, potentially delaying disease progression. Overall, personalized neuroscience represents a paradigm shift in understanding and addressing neurological and psychiatric conditions, paving the way for more effective, targeted interventions that improve patient outcomes and quality of life.
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : The role of beliefs, perception, and behavioural patterns in the evolution of psychophysical disorders
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States
Title : Cervical stenosis-induced chronic cerebrospinal fluid flow restriction as a contributing cause of dementia
Joe Sam Robinson, Mercer University, United States